JANX Stock Summary and Trading Ideas (Janux Therapeutics | NASDAQ:JANX)

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

What symbol and exchange does Janux Therapeutics shares trade?

Janux Therapeutics trades on the NASDAQ stock market under the symbol JANX.

What is Janux Therapeutics stock price doing today?

As of March 23, 2026, JANX stock price declined to $13.90 with 637,524 million shares trading.

What is Janux Therapeutics's Beta?

JANX has a beta of 1.00, meaning it tends to be less sensitive to market movements. JANX has a correlation of 0.03 to the broad based SPY ETF.

How much is Janux Therapeutics worth?

JANX has a market cap of $835.31 million. This is considered a Small Cap stock.

How much money does Janux Therapeutics make?

Last quarter Janux Therapeutics reported $0 in Revenue and -$.51 earnings per share. This fell short of revenue expectation by $-71,430 and exceeded earnings estimates by $.13.

What is the highest and lowest price Janux Therapeutics traded in the last 3 year period?

In the last 3 years, JANX traded as high as $71.71 and as low as $5.65.

What are the top ETFs holding Janux Therapeutics?

The top ETF exchange traded funds that JANX belongs to (by Net Assets): XBI, VTI, IWM, VXF, IBB.

Is Janux Therapeutics (JANX) a good investment?

JANX has underperformed the market in the last year with a return of -54.3%, while SPY returned +17.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in JANX shares. However, JANX has outperformed the market in the last 3 month and 2 week periods, returning +0.8% and +0.4%, while SPY returned -3.4% and -2.3%, respectively. This indicates JANX has been having a stronger performance recently.

What are the support and resistance levels for Janux Therapeutics (JANX)?

JANX support price is $13.66 and resistance is $14.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JANX shares will trade within this expected range on the day.